Consensus Virpax Pharmaceuticals, Inc.

Equities

VRPX

US9282512063

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-22 pm EDT			5-day change	1st Jan Change
0.7101 ^USD	-4.04%		-8.96%	-77.82%

May. 22	Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy	MT
May. 15	Virpax Prices Public Offering of Shares, Warrants; Shares Tumble	MT

Evolution of the average Target Price on Virpax Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

17d49e28f6c62e9a.T2zIceMzJPVvI4d8z66kRD85X-uO084YAR2aJHeY2z8.IC38JIJBTYA5FcoJqsXxMk16aob7p_9TUFXfbBbPvkYqB4sUjQVjuF4Rwg~94ca573fb702f73c998351fc6c0e9f32

Analyst Recommendations on Virpax Pharmaceuticals, Inc.

Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy	May. 22	MT
Analysis-Biotech IPOs to bloom with spotlight on startups with human trial data	23-02-13	RE
Maxim Group Initiates Coverage on Virpax Pharmaceuticals With Buy Rating, $4 Price Target	22-06-09	MT